908. Outcomes Research: Myeloid Malignancies: Poster I

A retrospective study to assess real world treatment patterns and outcomes in luspatercept treated patients with myelofibrosis associated anemia who required red blood cell transfusion in the United States

Ruxolitinib duration of treatment and effect on phlebotomy use among 2369 patients with polycythemia vera A real world analysis of the Medicare fee for service claims database

Quality of life and organization of care in patients with chronic myeloid leukemia CML within the lombardy hematologic network REL The CML OPERAP study

Global gender and geographic disparities in leukemia clinical trials authorship

Palliative care for AML patients on venetoclax based therapy A single center real world study

Outcomes of adolescent and young adult patients with AML treated on adult versus pediatric protocols

Impact of treatments with food restrictions on adherence and quality of life aspects among CML patients

Treatment cost per AE symptom free day of asciminib and second generation tyrosine kinase inhibitors in newly diagnosed patients with chronic myeloid leukemia

Real world treatment patterns and clinical outcomes in patients with essential thrombocythemia treated with cytoreductive therapy A retrospective analysis of electronic health records data

The impact of environmental air exposues on disease characteristics and outcomes in a cohort of patients with myelofibrosis

Impact of recipient sociodemographic factors on allogeneic transplant conditioning intensity and survival outcomes in myeloid malignancies A secondary analysis of CIBMTR data

Age ing study A prospective evaluation of geriatric patient reported and frailty assessments to predict outcomes in older adults with acute myeloid leukemia

Management of chronic myeloid leukaemia CML during pregnancy A systematic review of maternal and foetal outcomes

Real world experience with IDH inhibitors in Acute Myeloid Leukemia A german multicenter analysis with a focus on differentiation syndrome

Area deprivation index as a predictor of survival and treatment disparities in older adults with Acute Myeloid Leukemia A population based Study

Influence of air quality on clinical acuity at presentation in pediatric patients with newly diagnosed Acute Myeloid Leukemia

Hematologic predictors of serious infection and impact of serious infection on long term mortality in AML patients Insights from propensity matched real world cohorts

Dosing patterns of ponatinib in patients with chronic Phase chronic myeloid leukemia and effect on treatment Analysis of specialty pharmacy data in the United States

Impact of pre transplant anxiety and depression on outcomes of AML patients after allogeneic transplantation

Disparities and trends in hospice facility deaths among leukemia patients

County level analysis reveals two high incidence regions and potential environmental contributors to myeloid malignancies in Colorado

Burden of illness and hematocrit control among patients with high and low risk polycythemia vera receiving current standard of care treatment in the United States

Treatment associated healthcare utilization in older adults with AML A retrospective single center study

Outcomes of Acute Myeloid Leukemia patients undergoing hematopoietic stem cell transplantation with and without pre existing heart failure A national inpatient analysis

A real world analysis on the impact of GLP 1 receptor agonist use on all cause mortality and hematological outcomes in AML CML patients with obesity

Risk of thrombotic and bleeding events in patients with MPNs does SSRI use have an impact

Trends and disparities in hematologic malignancy and sepsis related mortality in adults aged ≥ 65 years in the United States from 1999 to2023 A CDC wonder database analysis